Log In
BCIQ
Print this Print this
 

Skelid, tiludronate

  Manage Alerts
Collapse Summary General Information
Company Sanofi
DescriptionBisphosphonate
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationPaget's disease
Indication DetailsTreat Paget's disease
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today